What does CUSIP 31773D101 represent in this 13F holders report?

CUSIP 31773D101 is the security identifier for FNCH - FINCH THERAPEUTICS GROUP INC - COM used to aggregate holder disclosures.

How many institutions held FNCH - FINCH THERAPEUTICS GROUP INC - COM in Q2 2021?

44 institutional investors reported FNCH - FINCH THERAPEUTICS GROUP INC - COM for Q2 2021. Use the holders table for investor-level position and value details.

FINCH THERAPEUTICS GROUP INC - COM (FNCH)

CUSIP: 31773D101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / COM
Total 13F shares: 5,512,277
Share change: -1,300,849
Total reported value: $77,243,000
Price per share: $14.07
Number of holders: 44
Value change: -$20,121,060
Number of buys: 30
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 31773D101?
CUSIP 31773D101 identifies FNCH - FINCH THERAPEUTICS GROUP INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 31773D101:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Institutional Holders of FINCH THERAPEUTICS GROUP INC - COM (FNCH) as of Q2 2021

As of 30 Jun 2021, FINCH THERAPEUTICS GROUP INC - COM (FNCH) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,512,277 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Bleichroeder LP, TRB Advisors LP, BlackRock Inc., Ikarian Capital, LLC, Aperture Investors, LLC, Sectoral Asset Management Inc, MSD Partners, L.P., Farallon Capital Management LLC, and VANGUARD GROUP INC. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.